INR 5510.55
(0.32%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 32.83 Billion INR | -39.12% |
2022 | 53.93 Billion INR | 20.51% |
2021 | 44.75 Billion INR | 28.96% |
2020 | 34.7 Billion INR | 0.15% |
2019 | 34.65 Billion INR | 6.99% |
2018 | 32.39 Billion INR | 15.8% |
2017 | 27.97 Billion INR | 17.63% |
2016 | 23.78 Billion INR | 11.17% |
2015 | 21.39 Billion INR | 34.82% |
2014 | 15.86 Billion INR | 36.83% |
2013 | 11.59 Billion INR | 21.78% |
2012 | 9.52 Billion INR | 20.85% |
2011 | 7.87 Billion INR | 23.79% |
2010 | 6.36 Billion INR | 17.96% |
2009 | 5.39 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 7.44 Billion INR | -19.08% |
2023 Q1 | 14.52 Billion INR | 5.85% |
2023 Q2 | 14.4 Billion INR | -0.83% |
2023 Q4 | 9.2 Billion INR | -33.35% |
2023 FY | 32.83 Billion INR | -39.12% |
2023 Q3 | 13.81 Billion INR | -4.09% |
2022 Q2 | 13.95 Billion INR | 3.1% |
2022 Q3 | 12.71 Billion INR | -8.92% |
2022 Q1 | 13.53 Billion INR | 39.72% |
2022 FY | 53.93 Billion INR | 20.51% |
2022 Q4 | 13.72 Billion INR | 7.93% |
2021 Q3 | 12.01 Billion INR | 0.87% |
2021 FY | 44.75 Billion INR | 28.96% |
2021 Q4 | 9.69 Billion INR | -19.33% |
2021 Q2 | 11.9 Billion INR | 6.89% |
2021 Q1 | 11.14 Billion INR | 39.54% |
2020 Q1 | 8.03 Billion INR | 29.68% |
2020 FY | 34.7 Billion INR | 0.15% |
2020 Q2 | 8.98 Billion INR | 11.87% |
2020 Q4 | 7.98 Billion INR | -17.7% |
2020 Q3 | 9.7 Billion INR | 7.97% |
2019 Q3 | 9.53 Billion INR | -1.03% |
2019 FY | 34.65 Billion INR | 6.99% |
2019 Q4 | 6.19 Billion INR | -35.05% |
2019 Q1 | 9.29 Billion INR | 26.73% |
2019 Q2 | 9.63 Billion INR | 3.72% |
2018 FY | 32.39 Billion INR | 15.8% |
2018 Q4 | 7.33 Billion INR | -12.51% |
2018 Q3 | 8.37 Billion INR | 0.17% |
2018 Q2 | 8.36 Billion INR | 0.6% |
2018 Q1 | 8.31 Billion INR | 0.95% |
2017 Q1 | 6.69 Billion INR | 0.21% |
2017 FY | 27.97 Billion INR | 17.63% |
2017 Q4 | 8.23 Billion INR | 4.04% |
2017 Q3 | 7.91 Billion INR | 8.32% |
2017 Q2 | 7.3 Billion INR | 9.24% |
2016 FY | 23.78 Billion INR | 11.17% |
2016 Q2 | 6.88 Billion INR | 12.46% |
2016 Q1 | 6.12 Billion INR | 4.45% |
2016 Q4 | 6.67 Billion INR | -1.8% |
2016 Q3 | 6.79 Billion INR | -1.26% |
2015 Q4 | 5.86 Billion INR | 11.42% |
2015 Q1 | 5.35 Billion INR | 52.17% |
2015 FY | 21.39 Billion INR | 34.82% |
2015 Q3 | 5.26 Billion INR | -9.76% |
2015 Q2 | 5.83 Billion INR | 8.78% |
2014 Q4 | 3.52 Billion INR | -13.45% |
2014 Q3 | 4.06 Billion INR | 9.06% |
2014 Q2 | 3.73 Billion INR | 0.0% |
2014 Q1 | 3.73 Billion INR | 0.0% |
2014 FY | 15.86 Billion INR | 36.83% |
2013 FY | 11.59 Billion INR | 21.78% |
2012 FY | 9.52 Billion INR | 20.85% |
2011 FY | 7.87 Billion INR | 23.79% |
2010 FY | 6.36 Billion INR | 17.96% |
2009 FY | 5.39 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sigachi Industries Limited | 579.88 Million INR | -5562.31% |
Ind-Swift Limited | 946.56 Million INR | -3368.851% |
Bajaj HealthCare Limited | 985.34 Million INR | -3232.335% |
Sakar Healthcare Limited | 204.07 Million INR | -15989.358% |
Aurobindo Pharma Limited | 55.65 Billion INR | 41.006% |
Innova Captab Limited | 931.03 Million INR | -3426.739% |
Divi's Laboratories Limited | 14.17 Billion INR | -131.722% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | -1227.471% |
Morepen Laboratories Limited | 1.98 Billion INR | -1552.117% |
Mankind Pharma Limited | 29.27 Billion INR | -12.169% |
Sequent Scientific Limited | 2.9 Billion INR | -1031.535% |
Wanbury Limited | 978.96 Million INR | -3254.049% |
Laurus Labs Limited | 11.9 Billion INR | -175.697% |
Nectar Lifesciences Limited | 932.7 Million INR | -3420.425% |
Glenmark Life Sciences Limited | 11.64 Billion INR | -182.071% |
Alembic Limited | 872.45 Million INR | -3663.505% |
Hikal Limited | 4.46 Billion INR | -635.584% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | -106.904% |
Neuland Laboratories Limited | 2.92 Billion INR | -1020.746% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -121.97% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 30.068% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -1391.822% |
Themis Medicare Limited | 1.12 Billion INR | -2816.598% |
RPG Life Sciences Limited | 1.63 Billion INR | -1907.643% |
Zydus Lifesciences Limited | 125.21 Billion INR | 73.776% |
Lupin Limited | 125.09 Billion INR | 73.752% |
Amrutanjan Health Care Limited | 2.09 Billion INR | -1468.024% |
Wockhardt Limited | 8.48 Billion INR | -287.205% |
Vaishali Pharma Limited | 84.02 Million INR | -38975.795% |
Aarti Pharmalabs Limited | 3.07 Billion INR | -968.013% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -7387.174% |
Jubilant Pharmova Limited | 14.45 Billion INR | -127.169% |
FDC Limited | 3.49 Billion INR | -838.208% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 65.753% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -7861.409% |
Eris Lifesciences Limited | 4.94 Billion INR | -564.281% |
Venus Remedies Limited | 1.91 Billion INR | -1613.473% |
ZIM Laboratories Limited | 1.01 Billion INR | -3141.177% |
Bliss GVS Pharma Limited | 1.41 Billion INR | -2213.592% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -56232.331% |
Caplin Point Laboratories Limited | 2.17 Billion INR | -1410.002% |
Shilpa Medicare Limited | 3.33 Billion INR | -884.801% |
Albert David Limited | 1.02 Billion INR | -3099.834% |
Ajanta Pharma Limited | 30.46 Billion INR | -7.788% |
Hester Biosciences Limited | 908.84 Million INR | -3512.847% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | -2240.694% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | -1185.58% |
Gufic Biosciences Limited | 1.18 Billion INR | -2667.175% |
Windlas Biotech Limited | 1 Billion INR | -3162.263% |
Procter & Gamble Health Limited | 2.99 Billion INR | -996.181% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -230920.896% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -20140.033% |
Granules India Limited | 10.31 Billion INR | -218.391% |
Aarti Drugs Limited | 1.16 Billion INR | -2712.47% |
Bal Pharma Limited | 555.62 Million INR | -5809.551% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 78.704% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -2956.733% |
Medicamen Biotech Limited | 335.16 Million INR | -9696.609% |
Unichem Laboratories Limited | 6.72 Billion INR | -388.19% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -7107.217% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -481351.613% |
Valiant Laboratories Limited | 138.02 Million INR | -23688.479% |
Orchid Pharma Limited | 800.77 Million INR | -4000.423% |
Medico Remedies Limited | 59.67 Million INR | -54923.041% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | -1445.77% |
Ipca Laboratories Limited | 18.98 Billion INR | -72.929% |
Brooks Laboratories Limited | 51.18 Million INR | -64055.92% |
Syncom Formulations (India) Limited | 345.63 Million INR | -9399.961% |
Piramal Enterprises Limited | 63.65 Billion INR | 48.415% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | -53.276% |
NATCO Pharma Limited | 10.05 Billion INR | -226.457% |
Suven Life Sciences Limited | 109.75 Million INR | -29817.995% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -71039.18% |
Strides Pharma Science Limited | 9.16 Billion INR | -258.371% |
Indoco Remedies Limited | 12.06 Billion INR | -172.236% |
Alpa Laboratories Limited | 127.38 Million INR | -25677.202% |
Lasa Supergenerics Limited | 291.17 Million INR | -11176.762% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -967.18% |